Should You Buy Biotech or Big Pharma in the COVID-19 Vaccine Race?

Should You Buy Biotech or Big Pharma in the COVID-19 Vaccine Race?

Clinical-stage biotechs including Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) and big-pharma players such as Pfizer (NYSE: PFE) and AstraZeneca (NYSE: AZN) are sharing the spotlight in the coronavirus vaccine race. Since the start of the year, for example, Moderna and Novavax are up 261% and 2,612%, respectively.